SOLIRIS
SOLIRIS
Approved
DIN Number
02322285
Drug Class
Human
Market Date
May 25, 2009
Company
HC
Alexion Pharma GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02322285
AIG Number0152512001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AJ01 ECULIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ECULIZUMABActive
Strength: 10 MG / ML
Monograph: ECULIZUMAB